Asgpr-binding compounds for the degradation of extracellular proteins
US-2024424108-A1 · Dec 26, 2024 · US
IL-2
IL-2 · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/55 |
| Official title | IL-2 |
| Display label | IL-2 |
| Total patents | 928 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 15 |
| 2016 | 27 |
| 2017 | 35 |
| 2018 | 36 |
| 2019 | 64 |
| 2020 | 83 |
| 2021 | 121 |
| 2022 | 122 |
| 2023 | 120 |
| 2024 | 165 |
| 2025 | 108 |
| 2026 | 32 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Fusions with cd8 antigen binding molecules for modulating immune cell function
US-2024417470-A1 · Dec 19, 2024 · US
Compositions and methods for targeted cytokine delivery
US-2024376169-A1 · Nov 14, 2024 · US
Fusion protein comprising interleukin-2 and interleukin-33
US-9840545-B2 · Dec 12, 2017 · US
Chemokine-cytokine fusion proteins and their applications
US-2017327554-A1 · Nov 16, 2017 · US
TH1/TH2 polarizing vaccines
US-9795661-B2 · Oct 24, 2017 · US
Bivalent IL-2 fusion toxins
US-9764006-B2 · Sep 19, 2017 · US
Cytokine-based fusion proteins for treatment of immune disorders
US-9745361-B2 · Aug 29, 2017 · US
Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use
US-2017233448-A1 · Aug 17, 2017 · US
Method of treating graft versus host disease using IL-2 muteins
US-9732134-B2 · Aug 15, 2017 · US
Methods and compositions relating to improved lentiviral vectors and their applications
US-9731033-B2 · Aug 15, 2017 · US
Modified SAK gene for the production of recombinant proteins
US-9670262-B2 · Jun 6, 2017 · US
Cell surface coupling of nanoparticles
US-2017080104-A1 · Mar 23, 2017 · US
Methods and compositions relating to restricted expression lentiviral vectors and their applications
US-2017067079-A1 · Mar 9, 2017 · US
Interleukin-2 muteins for the expansion of T-regulatory cells
US-9580486-B2 · Feb 28, 2017 · US
Methods for the diagnostic of an autoimmune disease
US-2017045512-A1 · Feb 16, 2017 · US
Superagonists, Partial Agonists and Antagonists of Interleukin-2
US-2017044229-A1 · Feb 16, 2017 · US
Mesenchymal stem cells for targeted cancer therapy
US-2017000886-A1 · Jan 5, 2017 · US
Methods and compositions relating to improved lentiviral vectors and their applications
US-2016375152-A1 · Dec 29, 2016 · US
In vivo targeting of cells with ligand-conjugated particles
US-2016375149-A1 · Dec 29, 2016 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/55?
- CPC C07K14/55 is the Cooperative Patent Classification code for “IL-2.”
- How many patents are filed under CPC C07K14/55 (IL-2)?
- Our database includes 928 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/55 growing?
- Publication counts under this code: 165 in 2024 vs 108 in 2025 (latest complete years).